PharmaShots | Incisive News in 3 Shots

Subscribe Now

CKD Limited

Chong Kun Dang Pharmaceutical Reports P-III Trials of CKD-701 (biosimilar, ranibizumab) for the Treatment of Neovascular Age-Related Macular Degeneration

Chong Kun Dang Pharmaceutical Reports P-III Trials of CKD-701 (biosimilar, ranibizumab) for the Treatment of Neovascular Age-Relat...

December 28, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us